Absolute 0 8 0 8 B-clinical_variable
neutrophil 9 19 9 19 I-clinical_variable
count 20 25 20 25 I-clinical_variable
( 26 27 26 27 I-clinical_variable
ANC 27 30 27 30 I-clinical_variable
) 30 31 30 31 I-clinical_variable
≥ 32 33 32 33 O
1.0 34 37 34 37 B-lower_bound
x 38 39 38 39 I-lower_bound
10 40 42 40 42 I-lower_bound
^ 42 43 42 43 I-lower_bound
9 43 44 43 44 I-lower_bound
/ 44 45 44 45 I-lower_bound
L 45 46 45 46 I-lower_bound

Active 0 6 47 53 O
Hepatitis 7 16 54 63 B-chronic_disease
C 17 18 64 65 I-chronic_disease
infection 19 28 66 75 I-chronic_disease

Active 0 6 76 82 B-chronic_disease
infection 7 16 83 92 I-chronic_disease
or 17 19 93 95 O
corneal 20 27 96 103 B-chronic_disease
ulcer 28 33 104 109 I-chronic_disease
( 34 35 110 111 O
e.g. 35 39 111 115 O
keratitis 40 49 116 125 B-chronic_disease
) 49 50 125 126 O

Alanine 0 7 127 134 B-clinical_variable
aminotransferase 8 24 135 151 I-clinical_variable
( 25 26 152 153 I-clinical_variable
ALT 26 29 153 156 I-clinical_variable
) 29 30 156 157 I-clinical_variable
≤ 31 32 158 159 O
1.5 33 36 160 163 B-upper_bound
x 37 38 164 165 I-upper_bound
ULN 39 42 166 169 I-upper_bound

Any 0 3 170 173 O
P 4 5 174 175 B-treatment
- 5 6 175 176 I-treatment
glycoprotein 6 18 176 188 I-treatment
( 19 20 189 190 I-treatment
P 20 21 190 191 I-treatment
- 21 22 191 192 I-treatment
gp 22 24 192 194 I-treatment
) 24 25 194 195 I-treatment
inducers 26 34 196 204 I-treatment
/ 34 35 204 205 I-treatment
inhibitors 35 45 205 215 I-treatment
or 46 48 216 218 O
strong 49 55 219 225 O
cytochrome 56 66 226 236 B-treatment
P4503A 67 73 237 243 I-treatment
( 74 75 244 245 I-treatment
CYP3A 75 80 245 250 I-treatment
) 80 81 250 251 I-treatment
inhibitors 82 92 252 262 I-treatment
within 93 99 263 269 O
14 100 102 270 272 B-upper_bound
days 103 107 273 277 I-upper_bound
prior 108 113 278 283 I-upper_bound
to 114 116 284 286 O
the 117 120 287 290 O
first 121 126 291 296 O
dose 127 131 297 301 O
of 132 134 302 304 O
study 135 140 305 310 O
drug 141 145 311 315 O

Any 0 3 316 319 O
anticancer 4 14 320 330 B-treatment
therapy 15 22 331 338 I-treatment
within 23 29 339 345 O
14 30 32 346 348 B-upper_bound
days 33 37 349 353 I-upper_bound
prior 38 43 354 359 I-upper_bound
to 44 46 360 362 O
the 47 50 363 366 O
first 51 56 367 372 O
dose 57 61 373 377 O
of 62 64 378 380 O
study 65 70 381 386 O
drug 71 75 387 391 O

Any 0 3 392 395 O
medical 4 11 396 403 B-chronic_disease
, 11 12 403 404 O
psychiatric 13 24 405 416 B-chronic_disease
, 24 25 416 417 O
addictive 26 35 418 427 O
or 36 38 428 430 O
other 39 44 431 436 O
kind 45 49 437 441 O
of 50 52 442 444 O
disorder 53 61 445 453 O
which 62 67 454 459 O
compromises 68 79 460 471 O
the 80 83 472 475 O
ability 84 91 476 483 O
of 92 94 484 486 O
the 95 98 487 490 O
subject 99 106 491 498 O
to 107 109 499 501 O
give 110 114 502 506 O
written 115 122 507 514 O
informed 123 131 515 523 O
consent 132 139 524 531 O
and/or 140 146 532 538 O
to 147 149 539 541 O
comply 150 156 542 548 O
with 157 161 549 553 O
procedures 162 172 554 564 O

Aspartate 0 9 565 574 B-clinical_variable
aminotransferase 10 26 575 591 I-clinical_variable
( 27 28 592 593 I-clinical_variable
AST 28 31 593 596 I-clinical_variable
) 31 32 596 597 I-clinical_variable
≤ 33 34 598 599 O
1.5 35 38 600 603 B-upper_bound
x 39 40 604 605 I-upper_bound
ULN 41 44 606 609 I-upper_bound

Currently 0 9 610 619 O
receiving 10 19 620 629 O
systemic 20 28 630 638 B-treatment
antimicrobial 29 42 639 652 I-treatment
treatment 43 52 653 662 I-treatment
for 53 56 663 666 O
active 57 63 667 673 B-chronic_disease
infection 64 73 674 683 I-chronic_disease
( 74 75 684 685 O
viral 75 80 685 690 B-chronic_disease
, 80 81 690 691 O
bacterial 82 91 692 701 B-chronic_disease
, 91 92 701 702 O
or 93 95 703 705 O
fungal 96 102 706 712 B-chronic_disease
) 102 103 712 713 O
at 104 106 714 716 O
the 107 110 717 720 O
time 111 115 721 725 O
of 116 118 726 728 O
first 119 124 729 734 O
dose 125 129 735 739 O
of 130 132 740 742 O
enfortumab 133 143 743 753 B-treatment
vedotin 144 151 754 761 I-treatment

Decompensated 0 13 762 775 O
liver 14 19 776 781 B-chronic_disease
disease 20 27 782 789 I-chronic_disease
as 28 30 790 792 O
evidenced 31 40 793 802 O
by 41 43 803 805 O
clinically 44 54 806 816 O
significant 55 66 817 828 O
ascites 67 74 829 836 B-chronic_disease
refractory 75 85 837 847 O
to 86 88 848 850 O
diuretic 89 97 851 859 B-treatment
therapy 98 105 860 867 I-treatment
, 105 106 867 868 O
hepatic 107 114 869 876 B-chronic_disease
encephalopathy 115 129 877 891 I-chronic_disease
, 129 130 891 892 O
or 131 133 893 895 O
coagulopathy 134 146 896 908 B-chronic_disease

Documented 0 10 909 919 O
history 11 18 920 927 O
of 19 21 928 930 O
a 22 23 931 932 O
cerebral 24 32 933 941 B-chronic_disease
vascular 33 41 942 950 I-chronic_disease
event 42 47 951 956 I-chronic_disease
( 48 49 957 958 O
stroke 49 55 958 964 B-chronic_disease
or 56 58 965 967 O
transient 59 68 968 977 B-chronic_disease
ischemic 69 77 978 986 I-chronic_disease
attack 78 84 987 993 I-chronic_disease
) 84 85 993 994 O
, 85 86 994 995 O
unstable 87 95 996 1004 B-chronic_disease
angina 96 102 1005 1011 I-chronic_disease
, 102 103 1011 1012 O
myocardial 104 114 1013 1023 B-chronic_disease
infarction 115 125 1024 1034 I-chronic_disease
, 125 126 1034 1035 O
or 127 129 1036 1038 O
cardiac 130 137 1039 1046 O
symptoms 138 146 1047 1055 O
( 147 148 1056 1057 O
including 148 157 1057 1066 O
congestive 158 168 1067 1077 B-chronic_disease
heart 169 174 1078 1083 I-chronic_disease
failure 175 182 1084 1091 I-chronic_disease
) 182 183 1091 1092 O
consistent 184 194 1093 1103 O
with 195 199 1104 1108 O
New 200 203 1109 1112 B-clinical_variable
York 204 208 1113 1117 I-clinical_variable
Heart 209 214 1118 1123 I-clinical_variable
Association 215 226 1124 1135 I-clinical_variable
Class 227 232 1136 1141 I-clinical_variable
III 233 236 1142 1145 B-lower_bound
- 236 237 1145 1146 O
IV 237 239 1146 1148 B-upper_bound
within 240 246 1149 1155 O
6 247 248 1156 1157 B-upper_bound
months 249 255 1158 1164 I-upper_bound
prior 256 261 1165 1170 I-upper_bound
to 262 264 1171 1173 O
the 265 268 1174 1177 O
first 269 274 1178 1183 O
dose 275 279 1184 1188 O
of 280 282 1189 1191 O
enfortumab 283 293 1192 1202 B-treatment
vedotin 294 301 1203 1210 I-treatment

Dose 0 4 1211 1215 O
Escalation 5 15 1216 1226 O
, 15 16 1226 1227 O
Renal 17 22 1228 1233 B-chronic_disease
insufficiency 23 36 1234 1247 I-chronic_disease
and 37 40 1248 1251 O
CPI 41 44 1252 1255 O
- 44 45 1255 1256 O
Treated 45 52 1256 1263 O
Expansion 53 62 1264 1273 O
cohorts 63 70 1274 1281 O

Dose 0 4 1282 1286 O
Escalation 5 15 1287 1297 O
, 15 16 1297 1298 O
Renal 17 22 1299 1304 B-chronic_disease
insufficiency 23 36 1305 1318 I-chronic_disease
, 36 37 1318 1319 O
NSCLC 38 43 1320 1325 B-cancer
and 44 47 1326 1329 O
CPI 48 51 1330 1333 B-treatment
- 51 52 1333 1334 O
Treated 52 59 1334 1341 O
Expansion 60 69 1342 1351 O
Cohorts 70 77 1352 1359 O

Eastern 0 7 1360 1367 B-clinical_variable
Cooperative 8 19 1368 1379 I-clinical_variable
Oncology 20 28 1380 1388 I-clinical_variable
Group 29 34 1389 1394 I-clinical_variable
( 35 36 1395 1396 I-clinical_variable
ECOG 36 40 1396 1400 I-clinical_variable
) 40 41 1400 1401 I-clinical_variable
performance 42 53 1402 1413 I-clinical_variable
status 54 60 1414 1420 I-clinical_variable
of 61 63 1421 1423 O
0 64 65 1424 1425 B-lower_bound
or 66 68 1426 1428 O
1 69 70 1429 1430 B-upper_bound

Hemoglobin 0 10 1431 1441 B-clinical_variable
≥ 11 12 1442 1443 O
9 13 14 1444 1445 B-lower_bound
g 15 16 1446 1447 I-lower_bound
/ 16 17 1447 1448 I-lower_bound
dL 17 19 1448 1450 I-lower_bound

Histologic 0 10 1451 1461 O
or 11 13 1462 1464 O
cytologic 14 23 1465 1474 O
diagnosis 24 33 1475 1484 O
of 34 36 1485 1487 O
NSCLC 37 42 1488 1493 B-cancer
( 43 44 1494 1495 O
squamous 44 52 1495 1503 B-cancer
or 53 55 1504 1506 I-cancer
non 56 59 1507 1510 I-cancer
- 59 60 1510 1511 I-cancer
squamous 60 68 1511 1519 I-cancer
or 69 71 1520 1522 I-cancer
NSCLC 72 77 1523 1528 I-cancer
- 77 78 1528 1529 O
not 78 81 1529 1532 O
specified 82 91 1533 1542 O
) 91 92 1542 1543 O

Histologically 0 14 1544 1558 O
confirmed 15 24 1559 1568 O
Transitional 25 37 1569 1581 B-cancer
Cell 38 42 1582 1586 I-cancer
Carcinoma 43 52 1587 1596 I-cancer
of 53 55 1597 1599 I-cancer
the 56 59 1600 1603 I-cancer
Urothelium 60 70 1604 1614 I-cancer
( 71 72 1615 1616 I-cancer
TCCU 72 76 1616 1620 I-cancer
) 76 77 1620 1621 I-cancer
( 78 79 1622 1623 O
i.e. 79 83 1623 1627 O
, 83 84 1627 1628 O
cancer 85 91 1629 1635 B-cancer
of 92 94 1636 1638 I-cancer
the 95 98 1639 1642 I-cancer
bladder 99 106 1643 1650 I-cancer
, 106 107 1650 1651 O
renal 108 113 1652 1657 B-cancer
pelvis 114 120 1658 1664 I-cancer
, 120 121 1664 1665 O
ureter 122 128 1666 1672 B-cancer
, 128 129 1672 1673 O
or 130 132 1674 1676 O
urethra 133 140 1677 1684 B-cancer

History 0 7 1685 1692 O
of 8 10 1693 1695 O
another 11 18 1696 1703 O
malignancy 19 29 1704 1714 B-cancer
within 30 36 1715 1721 O
3 37 38 1722 1723 B-upper_bound
years 39 44 1724 1729 I-upper_bound
before 45 51 1730 1736 I-upper_bound
the 52 55 1737 1740 O
first 56 61 1741 1746 O
dose 62 66 1747 1751 O
of 67 69 1752 1754 O
study 70 75 1755 1760 O
drug 76 80 1761 1765 O
, 80 81 1765 1766 O
or 82 84 1767 1769 O
any 85 88 1770 1773 O
evidence 89 97 1774 1782 O
of 98 100 1783 1785 O
residual 101 109 1786 1794 B-cancer
disease 110 117 1795 1802 I-cancer
from 118 122 1803 1807 O
a 123 124 1808 1809 O
previously 125 135 1810 1820 O
diagnosed 136 145 1821 1830 O
malignancy 146 156 1831 1841 O

History 0 7 1842 1849 O
of 8 10 1850 1852 O
corneal 11 18 1853 1860 B-treatment
transplantation 19 34 1861 1876 I-treatment

History 0 7 1877 1884 O
of 8 10 1885 1887 O
uncontrolled 11 23 1888 1900 O
diabetes 24 32 1901 1909 B-chronic_disease
mellitus 33 41 1910 1918 I-chronic_disease
or 42 44 1919 1921 O
diabetic 45 53 1922 1930 B-chronic_disease
neuropathy 54 64 1931 1941 I-chronic_disease
within 65 71 1942 1948 O
3 72 73 1949 1950 B-upper_bound
months 74 80 1951 1957 I-upper_bound
of 81 83 1958 1960 O
the 84 87 1961 1964 O
first 88 93 1965 1970 O
dose 94 98 1971 1975 O
of 99 101 1976 1978 O
study 102 107 1979 1984 B-treatment
drug 108 112 1985 1989 I-treatment

International 0 13 1990 2003 B-clinical_variable
normal 14 20 2004 2010 I-clinical_variable
ratio 21 26 2011 2016 I-clinical_variable
( 27 28 2017 2018 I-clinical_variable
INR 28 31 2018 2021 I-clinical_variable
) 31 32 2021 2022 I-clinical_variable
< 33 34 2023 2024 O
1.3 35 38 2025 2028 B-upper_bound
or 39 41 2029 2031 O
≤ 42 43 2032 2033 O
institutional 44 57 2034 2047 O
ULN 58 61 2048 2051 O
( 62 63 2052 2053 O
or 63 65 2053 2055 O
≤ 66 67 2056 2057 O
3.0 68 71 2058 2061 B-upper_bound
if 72 74 2062 2064 O
on 75 77 2065 2067 O
therapeutic 78 89 2068 2079 B-treatment
anticoagulation 90 105 2080 2095 I-treatment
) 105 106 2095 2096 O

Known 0 5 2097 2102 B-chronic_disease
Human 6 11 2103 2108 I-chronic_disease
Immunodeficiency 12 28 2109 2125 I-chronic_disease
Virus 29 34 2126 2131 I-chronic_disease
( 35 36 2132 2133 I-chronic_disease
HIV 36 39 2133 2136 I-chronic_disease
) 39 40 2136 2137 I-chronic_disease
or 41 43 2138 2140 O
Acquired 44 52 2141 2149 B-chronic_disease
Immune 53 59 2150 2156 I-chronic_disease
Deficiency 60 70 2157 2167 I-chronic_disease
Syndrome 71 79 2168 2176 I-chronic_disease
( 80 81 2177 2178 I-chronic_disease
AIDS 81 85 2178 2182 I-chronic_disease
) 85 86 2182 2183 I-chronic_disease

Known 0 5 2184 2189 O
sensitivity 6 17 2190 2201 O
to 18 20 2202 2204 O
any 21 24 2205 2208 O
of 25 27 2209 2211 O
the 28 31 2212 2215 O
ingredients 32 43 2216 2227 O
of 44 46 2228 2230 O
the 47 50 2231 2234 O
investigational 51 66 2235 2250 O
product 67 74 2251 2258 O
enfortumab 75 85 2259 2269 B-allergy_name
vedotin 86 93 2270 2277 I-allergy_name
( 94 95 2278 2279 I-allergy_name
ASG-22CE 95 103 2279 2287 I-allergy_name
) 103 104 2287 2288 I-allergy_name

Life 0 4 2289 2293 B-clinical_variable
expectancy 5 15 2294 2304 I-clinical_variable
of 16 18 2305 2307 O
≥ 19 20 2308 2309 O
3 21 22 2310 2311 B-lower_bound
months 23 29 2312 2318 I-lower_bound

Major 0 5 2319 2324 B-treatment
surgery 6 13 2325 2332 I-treatment
within 14 20 2333 2339 O
28 21 23 2340 2342 B-upper_bound
days 24 28 2343 2347 I-upper_bound
prior 29 34 2348 2353 I-upper_bound
to 35 37 2354 2356 O
first 38 43 2357 2362 O
dose 44 48 2363 2367 O
of 49 51 2368 2370 O
study 52 57 2371 2376 B-treatment
drug 58 62 2377 2381 I-treatment

Monocularity 0 12 2382 2394 B-chronic_disease

NSCLC 0 5 2395 2400 B-cancer
Expansion 6 15 2401 2410 O
Cohort 16 22 2411 2417 O

Negative 0 8 2418 2426 B-pregnancy
pregnancy 9 18 2427 2436 I-pregnancy
test 19 23 2437 2441 O
( 24 25 2442 2443 O
women 25 30 2443 2448 B-gender
of 31 33 2449 2451 O
childbearing 34 46 2452 2464 O
potential 47 56 2465 2474 O
) 56 57 2474 2475 O

Platelet 0 8 2476 2484 B-clinical_variable
count 9 14 2485 2490 I-clinical_variable
≥ 15 16 2491 2492 O
100 17 20 2493 2496 B-lower_bound
x 21 22 2497 2498 I-lower_bound
10 23 25 2499 2501 I-lower_bound
^ 25 26 2501 2502 I-lower_bound
9 26 27 2502 2503 I-lower_bound
/ 27 28 2503 2504 I-lower_bound
L 28 29 2504 2505 I-lower_bound

Preexisting 0 11 2506 2517 O
motor 12 17 2518 2523 B-clinical_variable
neuropathy 18 28 2524 2534 I-clinical_variable
Grade 29 34 2535 2540 I-clinical_variable
≥ 35 36 2541 2542 O
2 37 38 2543 2544 B-lower_bound

Preexisting 0 11 2545 2556 O
sensory 12 19 2557 2564 O
neuropathy 20 30 2565 2575 B-chronic_disease
Grade 31 36 2576 2581 B-clinical_variable
≥ 37 38 2582 2583 O
2 39 40 2584 2585 B-lower_bound

Routine 0 7 2586 2593 O
antimicrobial 8 21 2594 2607 B-treatment
prophylaxis 22 33 2608 2619 I-treatment
is 34 36 2620 2622 O
permitted 37 46 2623 2632 O

Serum 0 5 2633 2638 B-clinical_variable
albumin 6 13 2639 2646 I-clinical_variable
≥2.5 14 18 2647 2651 O
g 19 20 2652 2653 I-lower_bound
/ 20 21 2653 2654 I-lower_bound
dL 21 23 2654 2656 I-lower_bound

Sexually 0 8 2657 2665 O
active 9 15 2666 2672 O
fertile 16 23 2673 2680 O
subjects 24 32 2681 2689 O
, 32 33 2689 2690 O
and 34 37 2691 2694 O
their 38 43 2695 2700 O
partners 44 52 2701 2709 O
, 52 53 2709 2710 O
must 54 58 2711 2715 O
agree 59 64 2716 2721 B-contraception_consent
to 65 67 2722 2724 I-contraception_consent
use 68 71 2725 2728 I-contraception_consent
medically 72 81 2729 2738 I-contraception_consent
accepted 82 90 2739 2747 I-contraception_consent
double 91 97 2748 2754 I-contraception_consent
- 97 98 2754 2755 I-contraception_consent
barrier 98 105 2755 2762 I-contraception_consent
methods 106 113 2763 2770 I-contraception_consent
of 114 116 2771 2773 I-contraception_consent
contraception 117 130 2774 2787 I-contraception_consent
( 131 132 2788 2789 O
e.g. 132 136 2789 2793 O
, 136 137 2793 2794 O
barrier 138 145 2795 2802 O
methods 146 153 2803 2810 O
, 153 154 2810 2811 O
including 155 164 2812 2821 O
male 165 169 2822 2826 B-gender
condom 170 176 2827 2833 B-contraception_consent
, 176 177 2833 2834 O
female 178 184 2835 2841 B-gender
condom 185 191 2842 2848 O
, 191 192 2848 2849 O
or 193 195 2850 2852 O
diaphragm 196 205 2853 2862 B-contraception_consent
with 206 210 2863 2867 I-contraception_consent
spermicidal 211 222 2868 2879 I-contraception_consent
gel 223 226 2880 2883 I-contraception_consent
) 226 227 2883 2884 O
during 228 234 2885 2891 O
the 235 238 2892 2895 O
study 239 244 2896 2901 O
and 245 248 2902 2905 O
at 249 251 2906 2908 O
least 252 257 2909 2914 O
6 258 259 2915 2916 B-lower_bound
months 260 266 2917 2923 I-lower_bound
after 267 272 2924 2929 I-lower_bound
termination 273 284 2930 2941 O
of 285 287 2942 2944 O
study 288 293 2945 2950 O
therapy 294 301 2951 2958 B-treatment

Subject 0 7 2959 2966 O
must 8 12 2967 2971 O
have 13 17 2972 2976 O
failed 18 24 2977 2983 O
at 25 27 2984 2986 O
least 28 33 2987 2992 O
one 34 37 2993 2996 B-lower_bound
prior 38 43 2997 3002 B-treatment
chemotherapy 44 56 3003 3015 I-treatment
regimen 57 64 3016 3023 I-treatment
for 65 68 3024 3027 O
metastatic 69 79 3028 3038 B-cancer
disease 80 87 3039 3046 I-cancer
( 88 89 3047 3048 O
urothelial 89 99 3048 3058 B-cancer
and 100 103 3059 3062 O
bladder 104 111 3063 3070 B-cancer
cancer 112 118 3071 3077 I-cancer
subjects 119 127 3078 3086 O
are 128 131 3087 3090 O
not 132 135 3091 3094 O
required 136 144 3095 3103 O
to 145 147 3104 3106 O
have 148 152 3107 3111 O
failed 153 159 3112 3118 O
prior 160 165 3119 3124 O
chemotherapy 166 178 3125 3137 O
regimen 179 186 3138 3145 O
if 187 189 3146 3148 O
considered 190 200 3149 3159 O
unfit 201 206 3160 3165 O
for 207 210 3166 3169 O
cisplatin 211 220 3170 3179 B-treatment
- 220 221 3179 3180 I-treatment
based 221 226 3180 3185 I-treatment
chemotherapy 227 239 3186 3198 I-treatment
) 239 240 3198 3199 O

Subject 0 7 3200 3207 O
must 8 12 3208 3212 O
have 13 17 3213 3217 O
received 18 26 3218 3226 O
prior 27 32 3227 3232 B-treatment
treatment 33 42 3233 3242 I-treatment
with 43 47 3243 3247 I-treatment
a 48 49 3248 3249 I-treatment
CPI 50 53 3250 3253 I-treatment
in 54 56 3254 3256 I-treatment
the 57 60 3257 3260 I-treatment
metastatic 61 71 3261 3271 I-treatment
setting 72 79 3272 3279 I-treatment

Subjects 0 8 3280 3288 O
must 9 13 3289 3293 O
have 14 18 3294 3298 O
tumor 19 24 3299 3304 B-cancer
tissue 25 31 3305 3311 O
positive 32 40 3312 3320 O
( 41 42 3321 3322 O
IHC 42 45 3322 3325 B-clinical_variable
H 46 47 3326 3327 I-clinical_variable
- 47 48 3327 3328 O
score 48 53 3328 3333 O
≥150 54 58 3334 3338 O
) 58 59 3338 3339 O
for 60 63 3340 3343 O
Nectin-4 64 72 3344 3352 B-clinical_variable
expression 73 83 3353 3363 I-clinical_variable

Subjects 0 8 3364 3372 O
who 9 12 3373 3376 O
have 13 17 3377 3381 O
been 18 22 3382 3386 O
treated 23 30 3387 3394 O
for 31 34 3395 3398 O
Hepatitis 35 44 3399 3408 B-chronic_disease
C 45 46 3409 3410 I-chronic_disease
infection 47 56 3411 3420 O
can 57 60 3421 3424 O
be 61 63 3425 3427 O
included 64 72 3428 3436 O
if 73 75 3437 3439 O
they 76 80 3440 3444 O
have 81 85 3445 3449 O
documented 86 96 3450 3460 O
sustained 97 106 3461 3470 O
virologic 107 116 3471 3480 B-clinical_variable
response 117 125 3481 3489 I-clinical_variable
of 126 128 3490 3492 O
≥ 129 130 3493 3494 O
12 131 133 3495 3497 B-lower_bound
weeks 134 139 3498 3503 I-lower_bound

Subjects 0 8 3504 3512 O
with 9 13 3513 3517 O
Urothelial 14 24 3518 3528 B-cancer
Carcinoma 25 34 3529 3538 I-cancer
with 35 39 3539 3543 I-cancer
squamous 40 48 3544 3552 I-cancer
differentiation 49 64 3553 3568 I-cancer
or 65 67 3569 3571 I-cancer
mixed 68 73 3572 3577 I-cancer
cell 74 78 3578 3582 I-cancer
types 79 84 3583 3588 I-cancer
are 85 88 3589 3592 O
eligible 89 97 3593 3601 O

Subjects 0 8 3602 3610 O
with 9 13 3611 3615 O
a 14 15 3616 3617 O
negative 16 24 3618 3626 O
polymerase 25 35 3627 3637 B-treatment
chain 36 41 3638 3643 I-treatment
reaction 42 50 3644 3652 I-treatment
( 51 52 3653 3654 I-treatment
PCR 52 55 3654 3657 I-treatment
) 55 56 3657 3658 I-treatment
assay 57 62 3659 3664 O
are 63 66 3665 3668 O
permitted 67 76 3669 3678 O
with 77 81 3679 3683 O
appropriate 82 93 3684 3695 O
antiviral 94 103 3696 3705 B-treatment
prophylaxis 104 115 3706 3717 I-treatment

Subjects 0 8 3718 3726 O
with 9 13 3727 3731 O
a 14 15 3732 3733 O
positive 16 24 3734 3742 O
Hepatitis 25 34 3743 3752 B-chronic_disease
B 35 36 3753 3754 I-chronic_disease
surface 37 44 3755 3762 O
antigen 45 52 3763 3770 O
and/or 53 59 3771 3777 O
antihepatitis 60 73 3778 3791 B-chronic_disease
B 74 75 3792 3793 I-chronic_disease
core 76 80 3794 3798 O
antibody 81 89 3799 3807 O

Subjects 0 8 3808 3816 O
with 9 13 3817 3821 O
immunotherapy 14 27 3822 3835 B-treatment
related 28 35 3836 3843 O
adverse 36 43 3844 3851 O
events 44 50 3852 3858 O
requiring 51 60 3859 3868 O
high 61 65 3869 3873 O
doses 66 71 3874 3879 O
of 72 74 3880 3882 O
steroids 75 83 3883 3891 B-treatment

Subjects 0 8 3892 3900 O
with 9 13 3901 3905 O
nonmelanoma 14 25 3906 3917 B-cancer
skin 26 30 3918 3922 I-cancer
cancer 31 37 3923 3929 I-cancer
, 37 38 3929 3930 O
localized 39 48 3931 3940 B-cancer
prostate 49 57 3941 3949 I-cancer
cancer 58 64 3950 3956 I-cancer
treated 65 72 3957 3964 O
with 73 77 3965 3969 O
curative 78 86 3970 3978 O
intent 87 93 3979 3985 O
with 94 98 3986 3990 O
no 99 101 3991 3993 O
evidence 102 110 3994 4002 O
of 111 113 4003 4005 O
progression 114 125 4006 4017 O
, 125 126 4017 4018 O
low 127 130 4019 4022 O
- 130 131 4022 4023 O
risk 131 135 4023 4027 O
or 136 138 4028 4030 O
very 139 143 4031 4035 O
low 144 147 4036 4039 O
risk 148 152 4040 4044 O
localized 153 162 4045 4054 O
prostate 163 171 4055 4063 O
cancer 172 178 4064 4070 O
under 179 184 4071 4076 O
active 185 191 4077 4083 B-treatment
surveillance 192 204 4084 4096 I-treatment
/ 204 205 4096 4097 O
watchful 205 213 4097 4105 O
waiting 214 221 4106 4113 O
without 222 229 4114 4121 O
intent 230 236 4122 4128 O
to 237 239 4129 4131 O
treat 240 245 4132 4137 O
, 245 246 4137 4138 O
or 247 249 4139 4141 O
carcinoma 250 259 4142 4151 B-cancer
in 260 262 4152 4154 I-cancer
situ 263 267 4155 4159 I-cancer
of 268 270 4160 4162 O
any 271 274 4163 4166 O
time 275 279 4167 4171 O

Subjects 0 8 4172 4180 O
with 9 13 4181 4185 O
recurrent 14 23 4186 4195 O
disease 24 31 4196 4203 O
or 32 34 4204 4206 O
histologically 35 49 4207 4221 O
or 50 52 4222 4224 O
cytologically 53 66 4225 4238 O
confirmed 67 76 4239 4248 O
Stage 77 82 4249 4254 O
III 83 86 4255 4258 O
/ 86 87 4258 4259 O
IV 87 89 4259 4261 O
diagnosis 90 99 4262 4271 O
of 100 102 4272 4274 O
epithelial 103 113 4275 4285 B-cancer
ovarian 114 121 4286 4293 I-cancer
cancer 122 128 4294 4300 I-cancer
, 128 129 4300 4301 O
fallopian 130 139 4302 4311 B-cancer
tube 140 144 4312 4316 I-cancer
cancer 145 151 4317 4323 I-cancer
, 151 152 4323 4324 O
or 153 155 4325 4327 O
primary 156 163 4328 4335 B-cancer
peritoneal 164 174 4336 4346 I-cancer
carcinoma 175 184 4347 4356 I-cancer
who 185 188 4357 4360 O
have 189 193 4361 4365 O
previously 194 204 4366 4376 O
progressed 205 215 4377 4387 O
while 216 221 4388 4393 O
receiving 222 231 4394 4403 O
or 232 234 4404 4406 O
within 235 241 4407 4413 O
6 242 243 4414 4415 B-upper_bound
months 244 250 4416 4422 I-upper_bound
of 251 253 4423 4425 O
completing 254 264 4426 4436 O
a 265 266 4437 4438 O
platinum 267 275 4439 4447 B-treatment
- 275 276 4447 4448 I-treatment
containing 276 286 4448 4458 I-treatment
regimen 287 294 4459 4466 I-treatment

Thromboembolic 0 14 4467 4481 B-chronic_disease
events 15 21 4482 4488 O
and/or 22 28 4489 4495 O
bleeding 29 37 4496 4504 B-chronic_disease
disorders 38 47 4505 4514 I-chronic_disease
≤ 48 49 4515 4516 O
14 50 52 4517 4519 B-upper_bound
days 53 57 4520 4524 I-upper_bound
( 58 59 4525 4526 O
e.g. 59 63 4526 4530 O
, 63 64 4530 4531 O
deep 65 69 4532 4536 B-chronic_disease
vein 70 74 4537 4541 I-chronic_disease
thrombosis 75 85 4542 4552 I-chronic_disease
( 86 87 4553 4554 I-chronic_disease
DVT 87 90 4554 4557 I-chronic_disease
) 90 91 4557 4558 I-chronic_disease
or 92 94 4559 4561 O
pulmonary 95 104 4562 4571 B-chronic_disease
embolism 105 113 4572 4580 I-chronic_disease
( 114 115 4581 4582 I-chronic_disease
PE 115 117 4582 4584 I-chronic_disease
) 117 118 4584 4585 I-chronic_disease
) 118 119 4585 4586 O
prior 120 125 4587 4592 O
to 126 128 4593 4595 O
the 129 132 4596 4599 O
first 133 138 4600 4605 O
dose 139 143 4606 4610 O
of 144 146 4611 4613 O
study 147 152 4614 4619 O
drug 153 157 4620 4624 O

Total 0 5 4625 4630 B-clinical_variable
bilirubin 6 15 4631 4640 I-clinical_variable
≤ 16 17 4641 4642 O
1.5 18 21 4643 4646 B-upper_bound
x 22 23 4647 4648 I-upper_bound
ULN 24 27 4649 4652 I-upper_bound
( 28 29 4653 4654 I-upper_bound
upper 29 34 4654 4659 I-upper_bound
limit 35 40 4660 4665 I-upper_bound
of 41 43 4666 4668 I-upper_bound
normal 44 50 4669 4675 I-upper_bound
) 50 51 4675 4676 I-upper_bound

Uncontrolled 0 12 4677 4689 O
central 13 20 4690 4697 B-cancer
nervous 21 28 4698 4705 I-cancer
system 29 35 4706 4712 I-cancer
metastases 36 46 4713 4723 I-cancer

Uncontrolled 0 12 4724 4736 O
diabetes 13 21 4737 4745 B-chronic_disease
is 22 24 4746 4748 O
defined 25 32 4749 4756 O
as 33 35 4757 4759 O
hemoglobin 36 46 4760 4770 B-clinical_variable
A1C 47 50 4771 4774 I-clinical_variable
( 51 52 4775 4776 I-clinical_variable
HbA1c 52 57 4776 4781 I-clinical_variable
) 57 58 4781 4782 I-clinical_variable
≥ 59 60 4783 4784 O
8 61 62 4785 4786 O
% 62 63 4786 4787 O
or 64 66 4788 4790 O
HbA1c 67 72 4791 4796 O
> 73 74 4797 4798 O
7 75 76 4799 4800 B-lower_bound
to 77 79 4801 4803 O
< 80 81 4804 4805 O
8 82 83 4806 4807 O
% 83 84 4807 4808 O
with 85 89 4809 4813 O
associated 90 100 4814 4824 O
diabetes 101 109 4825 4833 O
symptoms 110 118 4834 4842 O
( 119 120 4843 4844 O
polyuria 120 128 4844 4852 B-chronic_disease
or 129 131 4853 4855 O
polydipsia 132 142 4856 4866 B-chronic_disease
) 142 143 4866 4867 O
that 144 148 4868 4872 O
are 149 152 4873 4876 O
not 153 156 4877 4880 O
otherwise 157 166 4881 4890 O
explained 167 176 4891 4900 O

Uncontrolled 0 12 4901 4913 O
glaucoma 13 21 4914 4922 B-chronic_disease
( 22 23 4923 4924 O
topical 23 30 4924 4931 B-treatment
medications 31 42 4932 4943 I-treatment
allowed 43 50 4944 4951 O
) 50 51 4951 4952 O

Uncontrolled 0 12 4953 4965 O
or 13 15 4966 4968 O
evolving 16 24 4969 4977 O
retinopathy 25 36 4978 4989 B-chronic_disease
, 36 37 4989 4990 O
wet 38 41 4991 4994 B-chronic_disease
macular 42 49 4995 5002 I-chronic_disease
degeneration 50 62 5003 5015 I-chronic_disease
, 62 63 5015 5016 O
uveitis 64 71 5017 5024 B-chronic_disease
, 71 72 5024 5025 O
papilledema 73 84 5026 5037 B-chronic_disease
, 84 85 5037 5038 O
or 86 88 5039 5041 O
optic 89 94 5042 5047 B-chronic_disease
disc 95 99 5048 5052 I-chronic_disease
disorder 100 108 5053 5061 I-chronic_disease

Use 0 3 5062 5065 O
of 4 6 5066 5068 O
any 7 10 5069 5072 O
investigational 11 26 5073 5088 B-treatment
drug 27 31 5089 5093 I-treatment
within 32 38 5094 5100 O
14 39 41 5101 5103 B-upper_bound
days 42 46 5104 5108 I-upper_bound
prior 47 52 5109 5114 I-upper_bound
to 53 55 5115 5117 O
the 56 59 5118 5121 O
first 60 65 5122 5127 O
dose 66 70 5128 5132 O
of 71 73 5133 5135 O
study 74 79 5136 5141 O
drug 80 84 5142 5146 O

chemotherapy 0 12 5147 5159 B-treatment

creatinine 0 10 5160 5170 B-clinical_variable
clearance 11 20 5171 5180 I-clinical_variable
estimate 21 29 5181 5189 O
≥15 30 33 5190 5193 O
ml 34 36 5194 5196 I-lower_bound
/ 36 37 5196 5197 I-lower_bound
min 37 40 5197 5200 I-lower_bound
and 41 44 5201 5204 O
< 45 46 5205 5206 O
30 46 48 5206 5208 B-upper_bound
ml 49 51 5209 5211 I-upper_bound
/ 51 52 5211 5212 I-upper_bound
min 52 55 5212 5215 I-upper_bound
by 56 58 5216 5218 O
Cockcroft 59 68 5219 5228 O
- 68 69 5228 5229 O
Gault 69 74 5229 5234 O
equation 75 83 5235 5243 O
or 84 86 5244 5246 O
as 87 89 5247 5249 O
measured 90 98 5250 5258 O
by 99 101 5259 5261 O
24 102 104 5262 5264 B-upper_bound
hour 105 109 5265 5269 I-upper_bound
urine 110 115 5270 5275 O
collection 116 126 5276 5286 O

creatinine 0 10 5287 5297 B-clinical_variable
clearance 11 20 5298 5307 I-clinical_variable
of 21 23 5308 5310 O
≥ 24 25 5311 5312 O
30 26 28 5313 5315 B-lower_bound
mL 29 31 5316 5318 I-lower_bound
/ 31 32 5318 5319 I-lower_bound
min 32 35 5319 5322 I-lower_bound
by 36 38 5323 5325 O
the 39 42 5326 5329 O
Cockcroft 43 52 5330 5339 B-clinical_variable
- 52 53 5339 5340 I-clinical_variable
Gault 53 58 5340 5345 I-clinical_variable
equation 59 67 5346 5354 I-clinical_variable
or 68 70 5355 5357 O
as 71 73 5358 5360 O
measured 74 82 5361 5369 O
by 83 85 5370 5372 O
24 86 88 5373 5375 O
hour 89 93 5376 5380 O
urine 94 99 5381 5386 O
collection 100 110 5387 5397 O

immunotherapy 0 13 5398 5411 B-treatment

monoclonal 0 10 5412 5422 B-treatment
antibody 11 19 5423 5431 I-treatment
therapy 20 27 5432 5439 I-treatment

no 0 2 5440 5442 O
red 3 6 5443 5446 B-treatment
blood 7 12 5447 5452 I-treatment
cell 13 17 5453 5457 I-treatment
or 18 20 5458 5460 O
platelet 21 29 5461 5469 B-treatment
transfusions 30 42 5470 5482 I-treatment
are 43 46 5483 5486 O
allowed 47 54 5487 5494 O
within 55 61 5495 5501 O
14 62 64 5502 5504 B-upper_bound
days 65 69 5505 5509 I-upper_bound
of 70 72 5510 5512 O
the 73 76 5513 5516 O
first 77 82 5517 5522 O
dose 83 87 5523 5527 O
of 88 90 5528 5530 O
enfortumab 91 101 5531 5541 B-treatment
vedotin 102 109 5542 5549 I-treatment

radiotherapy 0 12 5550 5562 B-treatment
or 13 15 5563 5565 O
any 16 19 5566 5569 O
other 20 25 5570 5575 O
agents 26 32 5576 5582 O
to 33 35 5583 5585 O
treat 36 41 5586 5591 O
cancer 42 48 5592 5598 B-cancer
( 49 50 5599 5600 O
anti 50 54 5600 5604 B-treatment
- 54 55 5604 5605 I-treatment
hormonal 55 63 5605 5613 I-treatment
therapy 64 71 5614 5621 I-treatment
given 72 77 5622 5627 O
as 78 80 5628 5630 O
adjuvant 81 89 5631 5639 B-treatment
therapy 90 97 5640 5647 I-treatment
for 98 101 5648 5651 O
early 102 107 5652 5657 O
- 107 108 5657 5658 O
stage 108 113 5658 5663 O
estrogen 114 122 5664 5672 O
receptor 123 131 5673 5681 O
( 132 133 5682 5683 O
ER 133 135 5683 5685 O
) 135 136 5685 5686 O
positive 137 145 5687 5695 O
breast 146 152 5696 5702 B-cancer
cancer 153 159 5703 5709 I-cancer
is 160 162 5710 5712 O
not 163 166 5713 5716 O
considered 167 177 5717 5727 O
cancer 178 184 5728 5734 B-treatment
therapy 185 192 5735 5742 I-treatment
for 193 196 5743 5746 O
the 197 200 5747 5750 O
purpose 201 208 5751 5758 O
of 209 211 5759 5761 O
this 212 216 5762 5766 O
protocol 217 225 5767 5775 O
) 225 226 5775 5776 O

≥ 0 1 5777 5778 O
40 2 4 5779 5781 B-lower_bound
mg 5 7 5782 5784 I-lower_bound
/ 7 8 5784 5785 I-lower_bound
day 8 11 5785 5788 I-lower_bound
of 12 14 5789 5791 O
prednisone 15 25 5792 5802 B-treatment

